NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs022190024

Registered date:31/03/2020

The efficacy of cPED for TMA

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedThrombotic microangiopathy
Date of first enrollment31/03/2020
Target sample size5
Countries of recruitment
Study typeInterventional
Intervention(s)cPED therapy

Outcome(s)

Primary OutcomeChanges in platelet counts before and after cPED
Secondary Outcome1. Incidence of adverse events. 2. Changes in blood test data before and after cPED. 3. Changes in severity assessment scores before and after cPED. 4. Number of days in ICU. 5. 28-day survival or discharge survival.

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteriaThe thrombotic microangiopathy patients whose physician presume that plasma exchange is effective.
Exclude criteriaPatients deemed inappropriate by the study director.

Related Information

Contact

Public contact
Name Kasumi Satoh
Address 1-1-1 Hondo, Akita city, Akita prefecture, 010-8543, Japan Akita Japan 010-8543
Telephone +81-18-884-6185
E-mail satohkasumi@med.akita-u.ac.jp
Affiliation Akita University Hospital
Scientific contact
Name Kasumi Satoh
Address 1-1-1 Hondo, Akita city, Akita prefecture, 010-8543, Japan Akita Japan 010-8543
Telephone +81-18-884-6185
E-mail satohkasumi@med.akita-u.ac.jp
Affiliation Akita University Hospital